Detalhe da pesquisa
1.
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
Ann Oncol
; 30(9): 1417-1427, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268127
2.
[HER2 testing in gastric cancer - results of a German expert meeting]. / HER2-Testung beim Magenkarzinom - Ergebnisse eines deutschen Expertentreffens.
Z Gastroenterol
; 54(8): 791-6, 2016 Aug.
Artigo
em Alemão
| MEDLINE | ID: mdl-27529529
3.
[HER2 testing in gastric cancer : Results of a meeting of German experts]. / HER2-Testung beim Magenkarzinom : Ergebnisse eines deutschen Expertentreffens.
Pathologe
; 37(4): 361-6, 2016 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-27376648
4.
[Predictive PD-L1 immunohistochemistry for non-small cell lung cancer : Current state of the art and experiences of the first German harmonization study]. / Prädiktive PD-L1-Immunhistochemie beim nichtkleinzelligen Bronchialkarzinom : Aktueller Stand und Erfahrungen der ersten deutschen Harmonisierungsstudie.
Pathologe
; 37(6): 557-567, 2016 Nov.
Artigo
em Alemão
| MEDLINE | ID: mdl-27510417
5.
[Subgroup Analysis of the Non-interventional REASON Study: PFS and OS According to Age, Smoking History, Gender, and Histology in NSCLC Patients Treated with Gefitinib or Chemotherapy]. / Subgruppenanalyse aus der nicht-interventionellen Beobachtungsstudie REASON: PFS und OS gemäß Alter, Raucherstatus, Geschlecht und histologischem Subtyp unter Verwendung von Gefitinib bzw. chemotherapeutischer Behandlung bei NSCLC-Patienten.
Pneumologie
; 70(9): 579-88, 2016 Sep.
Artigo
em Alemão
| MEDLINE | ID: mdl-27603946
6.
[Exon-dependent Subgroup-analysis of the Non-interventional REASON-Study: PFS and OS in EGFR-mutated NSCLC Patients Treated with Gefitinib or Chemotherapy]. / Exonabhängige Subgruppenanalyse der nicht-interventionellen REASON-Studie: PFS und OS beim EGFR-mutierten NSCLC mit Behandlung von Gefitinib versus Chemotherapie.
Pneumologie
; 70(8): 514-21, 2016 Aug.
Artigo
em Alemão
| MEDLINE | ID: mdl-27512931
7.
[ALK-Diagnostics in NSCLC - Immunohistochemistry (IHC) and/or Fluorescence-in-situ Hybridisation (FISH)]. / ALK-Testung beim nicht-kleinzelligen Lungenkarzinom (NSCLC): Immunhistochemie (IHC) und/oder Fluoreszenz-in-situ-Hybridisierung (FISH)?
Pneumologie
; 70(4): 277-81, 2016 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-26984109
8.
[Molecular pathology for breast cancer: Importance of the gene expression profile]. / Molekulare Pathologie beim Mammakarzinom: Wertigkeit der Genexpressionsprofile.
Pathologe
; 36(2): 145-53, 2015 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-25836324
9.
Cancer beyond organ and tissue specificity: next-generation-sequencing gene mutation data reveal complex genetic similarities across major cancers.
Int J Cancer
; 135(10): 2362-9, 2014 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24706491
10.
Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.
Br J Cancer
; 111(2): 413-20, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24983368
11.
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study.
Ann Oncol
; 25(5): 1025-32, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24562449
12.
[Nasopharyngeal space-occupying lesion with middle ear effusion. Malignant or benign?]. / Nasopharyngeale Raumforderung mit assoziiertem Paukenerguss. Ein maligner Prozess?
Pathologe
; 35(4): 379-82, 2014 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-24401934
13.
Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer.
Ann Oncol
; 24(9): 2316-24, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23661292
14.
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy.
Ann Oncol
; 24(3): 632-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23131391
15.
[Breast cancer: current recommendations for pathologists on the basis of the S3 guidelines]. / Mammakarzinom: aktuelle Empfehlungen für Pathologen auf Basis der S3-Leitlinie.
Pathologe
; 34(4): 293-302; quiz 303-4, 2013 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-23793365
16.
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer.
Br J Cancer
; 107(11): 1892-900, 2012 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23079573
17.
SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study.
Ann Oncol
; 28(11): 2900, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27578776
18.
Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression.
Nat Med
; 3(4): 447-50, 1997 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9095180
19.
[Statement of the German Society for Pathology and the working group thoracic oncology of the working group oncology/German Cancer Society on ALK testing in NSCLC: Immunohistochemistry and/or FISH?]. / Stellungnahme der DGP und der AG Thorakale Onkologie der AG Onkologie/Deutsche Krebsgesellschaft e. V. zur ALK-Testung beim NSCLC: Immunhistochemie und/oder FISH?
Pathologe
; 37(2): 187-91, 2016 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-26984297
20.
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype.
Br J Cancer
; 102(12): 1736-45, 2010 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-20531416